Ribociclib (LEE011)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ribociclib (LEE011), covering 2019-06-03 to 2025-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors [Phase 1]